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LETTERTO THE EDITOR
Autoantibody in Mucous Membrane Pemphigoid Binds to
an Intracellular Epitope on Human b4 Integrin and Causes
Basement Membrane Zone Separation in Oral Mucosa in an
Organ Culture Model
To the Editor:
Mucous membrane pemphigoid (MMP) is a rare vesiculobullous
disease, which involves the oral, ocular, and other mucous
membranes. Anti-basement membrane zone (anti-BMZ) autoan-
tibodies with di¡erent speci¢cities recognize di¡erent target
molecules present in the BMZ, many of which have been
recently described (Scully et al, 1999). A subset of MMP patients
whose disease is limited to, or principally involves, the conjuncti-
va are known to have ocular cicatricial pemphigoid (OCP)
(Foster, 1986).
In our earlier studies, we demonstrated that sera of patients
with OCP bind to the human B4 molecule in human skin,
conjunctiva, and tumor cell lysates (Tyagi et al, 1996; Chan et al,
1999). Our recent observations indicate that the OCP autoanti-
body recognizes only the intracellular domain of human b4
integrin and not the extracellular domain (Bhol et al, 2000).
In subsequent studies we have identi¢ed that the antibody binds
to a peptide (IC 3.4), within the intracellular portion of human
b4 integrin (Kumari et al, 2001). The presence of intracellular
antigen in human autoimmune disease has been described by
several investigators (Alarcon-Segovia et al, 1978; Golan et al,
1992; Reichlin, 1995). In this study, we used several clones repre-
senting fragments of the intracellular portions of B4 (IC 1.0, IC
2.0, IC 3.0, IC 3.4) and tested their binding to sera from 10 MMP
patients with multiple mucosal involvements, with active disease.
All the MMP sera demonstrated binding to the BMZ of normal
skin, conjunctiva, and buccal mucosa, and to the epidermal
side of the salt split skin, by indirect immuno£uorescence (indir-
ect immuno£uorescence titer ranged from 1:80 to 1:640),
and bound to the recombinant fusion protein representing
IC 3.0 and IC 3.4 fragments only, produced in Escherichia coli, in
an immunoblot assay (Fig 1a). These results indicated that,
for MMP sera, the dominant antibody binding epitope is
IC 3.4 (83 amino acids). Sera from rabbit immunized with IC 3.4
protein demonstrated binding to IC 3.4 fusion protein (Fig 1).
Normal human sera, preimmune rabbit sera, and sera from
patients with pemphigus vulgaris did not bind to this fragment
of b4 integrin.
In this, our purpose was to determine the potential role of IC
3.4 in the pathogenesis of MMP and the ability of antibodies to
IC 3.4 to produce separation of epithelial cells from the BMZ, in
an organ culture model, using normal human buccal mucosa.
Such studies have been done using normal human conjunctiva
(Chan et al, 1999) but not with other mucosa. As oral mucosa is
frequently involved in MMP, it was important to determine if
the possible role for antibody to IC 3.4 was identical. Sera from
10 MMP patients produced BMZ separation, identical to that
observed in vivo, as did rabbit antibodies to human IC 3.0 or IC
3.4 (Fig 2).
These observations strongly suggest that anti-BMZ antibodies
in the sera of MMP patients target the same peptide in the intra-
cellular portions of B4 (IC 3.4) as do autoantibodies in OCP.
Hence these observations have wider implications. It is possible
that a similar mechanism may involve other mucosae involved
in MMP.
It has been reported that a di¡erent subset of MMP, involving
multiple mucous membranes, produce antibodies to laminin 5
(Kirtschig et al, 1995).The sera of patients with antibodies to lami-
nin 5 bind to the dermal side of the salt split skin. The sera
of patients tested in our study do not contain autoantibodies to
laminin 5 (Kumari et al, 2001) and bind to the epidermal side of
the salt split skin.
As MMP has a heterogeneous clinical pro¢le and clinical
course, it would appear that there could be several antigens in-
volved alone or in combination in generating or maintaining
the autoimmune response. Some investigators have demonstrated
binding of MMP sera to bullous pemphigoid (BP 180, BPAg2). It
yet remains to be proven, however, whether the antibody to BP
Ag2 is the primary disease producing autoantibody or is pro-
duced as a secondary antibody. Neonatal BALB/c mice injected
with antibodies to BP Ag2 do not develop mucosal disease.
Figure1. Binding speci¢city of sera to IC 3.0 and IC 3.4. Immunoblot
analysis of fusion proteins produced by clones representing IC 3.0 and IC
3.4 fragments, presented in panel A and panel B, respectively.The fusion pro-
teins in lane 1 in both the panels are immunoblotted with MMP sera. Note
anE37 kDa band indicating binding to IC 3.0, and anE10 kDa band in-
dicating binding to IC 3.4 by MMP sera. The fusion proteins in lane 2 in
panels A and B are immunoblotted with rabbit antibody to IC 3.0 and IC
3.4 fragments, respectively. The presence of an E37 kDa band indicates
binding to IC 3.0 and an E10 kDa band indicates binding to IC 3.4. The
fusion proteins in lane 3 in both the panels were immunoblotted with anti-
body to the cytoplasmic domain of b4 integrin. Note binding to IC 3.0 as
demonstrated by the presence of an E37 kDa band, and absence of bind-
ing to IC 3.4. The fusion proteins in lanes 4 and 5 in both the panels were
immunoblotted with normal human serum and preimmune rabbit serum,
respectively. Note absence of binding either to IC 3.0 (E37 kDa) or IC 3.4
(E10 kDa).
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Hence the speci¢c role for antibodies to BPAg2 in the pathogen-
esis of MMP is not yet clear.
Investigators studying MMP may be able to obtain oral muco-
sa more easily than human conjunctiva. The availability of an or-
gan culture model will permit rapid advances in understanding
the multiple steps involved in the pathogenesis. It will also help
us understand why certain mucosae are more frequently involved
than others. If the multistep pathogenesis is delineated, attempts
to arrest progression may be possible.
This model also provides an opportunity to study the mechan-
ism by which autoantibodies that target intracellular antigens
gain access to them. If this process is better understood, the mod-
el has the capacity for testing new biologic agents to arrest or pre-
vent the progression of the disease process, if delivered locally or
speci¢cally targeted when administered systemically.
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Figure 2. Organ culture model to demonstrate BMZ separation of
buccal mucosa. In vitro organ culture model of normal human buccal
mucosa incubated with (a) MMP serum, (b), (c) rabbit antibody to IC 3.0
and IC 3.4 fragments, respectively, (d) PV serum, (e), (f) normal human ser-
um and preimmune rabbit serum, respectively. In the normal human buc-
cal mucosa section cultured with MMP serum and rabbit antibodies to IC
3.0 and IC 3.4 histologic identical BMZ separation was observed. Pemphi-
gus vulgaris serum produced acantholysis of epithelial cells in the buccal
mucosa, serving as a positive control for the assay. Normal human serum
and preimmune rabbit serum did not produce BMZ separation.
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